Plasma-based COVID-19 treatments in low-and middle-income countries and the risk of transfusion-transmitted infections

Ethical principles should prevail in the collection, testing and use of COVID-19 convalescent plasma (CCP) for human research in low- and middle- income countries. To appropriately guarantee safety, only blood establishments that comply with recognized quality standards should collect CCP.

Detalles Bibliográficos
Autores principales: Epstein, Jay, Martin Smid, W., Wendel, Silvano, Somuah, Daniel, Burnouf, Thierry
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Comment
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7642349/
https://www.ncbi.nlm.nih.gov/pubmed/33298976
http://dx.doi.org/10.1038/s41541-020-00256-6
_version_ 1783606065423712256
author Epstein, Jay
Martin Smid, W.
Wendel, Silvano
Somuah, Daniel
Burnouf, Thierry
author_facet Epstein, Jay
Martin Smid, W.
Wendel, Silvano
Somuah, Daniel
Burnouf, Thierry
author_sort Epstein, Jay
collection PubMed
description Ethical principles should prevail in the collection, testing and use of COVID-19 convalescent plasma (CCP) for human research in low- and middle- income countries. To appropriately guarantee safety, only blood establishments that comply with recognized quality standards should collect CCP.
format Online
Article
Text
id pubmed-7642349
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-76423492020-11-06 Plasma-based COVID-19 treatments in low-and middle-income countries and the risk of transfusion-transmitted infections Epstein, Jay Martin Smid, W. Wendel, Silvano Somuah, Daniel Burnouf, Thierry NPJ Vaccines Comment Ethical principles should prevail in the collection, testing and use of COVID-19 convalescent plasma (CCP) for human research in low- and middle- income countries. To appropriately guarantee safety, only blood establishments that comply with recognized quality standards should collect CCP. Nature Publishing Group UK 2020-11-03 /pmc/articles/PMC7642349/ /pubmed/33298976 http://dx.doi.org/10.1038/s41541-020-00256-6 Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Comment
Epstein, Jay
Martin Smid, W.
Wendel, Silvano
Somuah, Daniel
Burnouf, Thierry
Plasma-based COVID-19 treatments in low-and middle-income countries and the risk of transfusion-transmitted infections
title Plasma-based COVID-19 treatments in low-and middle-income countries and the risk of transfusion-transmitted infections
title_full Plasma-based COVID-19 treatments in low-and middle-income countries and the risk of transfusion-transmitted infections
title_fullStr Plasma-based COVID-19 treatments in low-and middle-income countries and the risk of transfusion-transmitted infections
title_full_unstemmed Plasma-based COVID-19 treatments in low-and middle-income countries and the risk of transfusion-transmitted infections
title_short Plasma-based COVID-19 treatments in low-and middle-income countries and the risk of transfusion-transmitted infections
title_sort plasma-based covid-19 treatments in low-and middle-income countries and the risk of transfusion-transmitted infections
topic Comment
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7642349/
https://www.ncbi.nlm.nih.gov/pubmed/33298976
http://dx.doi.org/10.1038/s41541-020-00256-6
work_keys_str_mv AT epsteinjay plasmabasedcovid19treatmentsinlowandmiddleincomecountriesandtheriskoftransfusiontransmittedinfections
AT martinsmidw plasmabasedcovid19treatmentsinlowandmiddleincomecountriesandtheriskoftransfusiontransmittedinfections
AT wendelsilvano plasmabasedcovid19treatmentsinlowandmiddleincomecountriesandtheriskoftransfusiontransmittedinfections
AT somuahdaniel plasmabasedcovid19treatmentsinlowandmiddleincomecountriesandtheriskoftransfusiontransmittedinfections
AT burnoufthierry plasmabasedcovid19treatmentsinlowandmiddleincomecountriesandtheriskoftransfusiontransmittedinfections

Ejemplares similares